Day: September 8, 2025

(All dollar amounts are expressed in Canadian dollars, unless otherwise noted.) TORONTO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Kinross Gold Corporation (“Kinross”) (TSX: K, NYSE: KGC) announced today that it has sold an aggregate of 29,850,984 common shares (“Shares”) of Asante Gold Corporation (“Asante”) representing approximately 4.2% of the outstanding Shares and approximately 44.7% of the Shares held by Kinross. The Shares were sold at a price per Share of $1.55 (not including commission), representing an aggregate sale price of C$46,269,025.20. Prior to the sale, Kinross held approximately 9.4% of the outstanding Shares and up to 18% of the Shares, on a partially-diluted basis, assuming conversion of all convertible instruments held by Kinross. After the sale, Kinross holds 36,927,650 Shares, 5,000,000 warrants to purchase Shares...

HFS Research Report Recognizes Concentrix for Intelligent Transformation and Client Results NEWARK, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, today announced it has been named a Market Leader in HFS Research’s 2025 Digital Marketing and Sales Services Horizon report, earning recognition as the go-to intelligent transformation partner for global enterprises. Each year, HFS Research spotlights the companies redefining how innovation drives value across the sales and marketing lifecycle. This year, Concentrix rose from disruptor to top-tier leader, earning a Market Leader designation for its rapid growth in digital marketing and B2B sales—and for helping clients boost sales, win market share, and sell complex products without simply adding more salespeople....

CoinShares International Limited (“CoinShares”) Vine Hill Capital Investment Corp., a special purpose acquisition company listed on the Nasdaq Stock Market (“Vine Hill”), and Odysseus Holdings Limited, a newly formed Jersey entity, (“Odysseus Holdings”)1 today jointly announce that CoinShares, Vine Hill and Odysseus Holdings have agreed on a joint merger plan including a court-sanctioned Scheme of Arrangement (as defined below) under Jersey Law between CoinShares and its shareholders (such joint merger plan and the Scheme of Arrangement, together, the “Transaction”), in order to facilitate a change of listing venue for CoinShares ordinary shares from Nasdaq Stockholm to the Nasdaq Stock Market in the United States, or any other public stock market or exchange in the United States as may be agreed between CoinShares and Vine Hill. The total...

LIBERTY Endovascular Robotic System*Microbot Medical® Receives FDA 510(k) Clearance for Its LIBERTY® Endovascular Robotic SystemAccelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company’s Initial Addressable Market Includes Approximately 2.5 Million Peripheral Endovascular Procedures in the U.S. Annually CEO, President & Chairman to Present Live Webcast at the H.C. Wainwright Annual Investor Conference on September 9, 2025, at 9 AM ET. HINGHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), developer and manufacturer of the innovative LIBERTY® Endovascular Robotic System, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the LIBERTY® System, the first FDA cleared single-use,...

PLAY carried 124,286 passengers in August 2025, compared to 187,960 passengers in August 2024. The difference year-on-year is primarily driven by the airline’s strategic shift in fleet deployment, with fewer aircraft operating within PLAY’s own route network due to ACMI leasing agreements with other operators. Despite the reduced capacity, the load factor was 89.6%, compared to 91.6% in August 2024. This slight decrease is a natural reflection of PLAY’s transition from a VIA-focused network, which typically achieves higher load factors, to a leisure-focused model. Leisure routes tend to have lower load factors as they do not benefit from large connecting flows, but they generate significantly higher yields. In August, PLAY’s unit revenue reached its highest level ever for the month of August, demonstrating the success of this strategic...

ALK (ALKB:DC / OMX: ALK B) today announced that real-world evidence evaluating the clinical performance of the nasal adrenaline spray neffy® in US patients experiencing anaphylaxis symptoms during oral food challenge and allergen immunotherapy has been accepted for scientific publication. The findings represent the first large-scale analysis of treatment outcomes with neffy® during routine clinical practice and were accepted for publishing as a correspondence in the Annals of Allergy, Asthma and Immunology, the official journal of the American College of Allergy, Asthma and Immunology. The analysis showed that 89.2% of 545 patients experiencing anaphylaxis symptoms during oral food challenge and allergen immunotherapy were successfully treated with a single dose of neffy® by a healthcare provider, while 10.8% of the 545 patients required...

SALT LAKE CITY, Utah, Sept. 08, 2025 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics innovator specializing in biomedical applications of silicon nitride (Si₃N₄), today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,099,431 shares of common stock of the Company originally issued in February 2025, having an exercise price of $3.32 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-3 (No. 333-285932). H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. In consideration for the immediate exercise of the warrants for cash and the payment of additional...